View in EDS

Intraocular delivery of crystalline sorafenib provides sustained, potent inhibition of wet age-related macular degeneration.

Saved in:
Bibliographic Details
Title: Intraocular delivery of crystalline sorafenib provides sustained, potent inhibition of wet age-related macular degeneration.
Authors: Lu H; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Rakoski AI; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Biomedical Engineering, Translational Tissue Engineering Center, Johns Hopkins School of Medicine, Baltimore, MD, USA., Ri K; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Zhou L; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Shi L; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Cho H; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Wu S; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Chen SS; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Biomedical Engineering, Translational Tissue Engineering Center, Johns Hopkins School of Medicine, Baltimore, MD, USA., Neill AN; Department of Chemistry, The Johns Hopkins University, Baltimore, MD, USA., Catazaro J; Department of Chemistry, The Johns Hopkins University, Baltimore, MD, USA., Wong VW; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Biomedical Engineering, Translational Tissue Engineering Center, Johns Hopkins School of Medicine, Baltimore, MD, USA., Yoo A; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Biomedical Engineering, Translational Tissue Engineering Center, Johns Hopkins School of Medicine, Baltimore, MD, USA., Wilson DS; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Biomedical Engineering, Translational Tissue Engineering Center, Johns Hopkins School of Medicine, Baltimore, MD, USA., Doloff JC; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Biomedical Engineering, Translational Tissue Engineering Center, Johns Hopkins School of Medicine, Baltimore, MD, USA; Department of Materials Science and Engineering, Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, MD, USA; Department of Oncology, Division of Cancer Immunology, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Sidney-Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Bloomberg∼Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address: jcdoloff@jhu.edu., Duh EJ; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address: eduh@jhmi.edu.
Source: Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2026 Jun 18; Vol. 397, pp. 115120. Date of Electronic Publication: 2026 Jun 18.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 8607908 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4995 (Electronic) Linking ISSN: 01683659 NLM ISO Abbreviation: J Control Release Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42314988
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Intraocular delivery of crystalline sorafenib provides sustained, potent inhibition of wet age-related macular degeneration.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lu+H%22">Lu H</searchLink>; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Rakoski+AI%22">Rakoski AI</searchLink>; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Biomedical Engineering, Translational Tissue Engineering Center, Johns Hopkins School of Medicine, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Ri+K%22">Ri K</searchLink>; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Zhou+L%22">Zhou L</searchLink>; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Shi+L%22">Shi L</searchLink>; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Cho+H%22">Cho H</searchLink>; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Wu+S%22">Wu S</searchLink>; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Chen+SS%22">Chen SS</searchLink>; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Biomedical Engineering, Translational Tissue Engineering Center, Johns Hopkins School of Medicine, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Neill+AN%22">Neill AN</searchLink>; Department of Chemistry, The Johns Hopkins University, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Catazaro+J%22">Catazaro J</searchLink>; Department of Chemistry, The Johns Hopkins University, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Wong+VW%22">Wong VW</searchLink>; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Biomedical Engineering, Translational Tissue Engineering Center, Johns Hopkins School of Medicine, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Yoo+A%22">Yoo A</searchLink>; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Biomedical Engineering, Translational Tissue Engineering Center, Johns Hopkins School of Medicine, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Wilson+DS%22">Wilson DS</searchLink>; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Biomedical Engineering, Translational Tissue Engineering Center, Johns Hopkins School of Medicine, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Doloff+JC%22">Doloff JC</searchLink>; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Biomedical Engineering, Translational Tissue Engineering Center, Johns Hopkins School of Medicine, Baltimore, MD, USA; Department of Materials Science and Engineering, Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, MD, USA; Department of Oncology, Division of Cancer Immunology, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Sidney-Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Bloomberg∼Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address: jcdoloff@jhu.edu.<br /><searchLink fieldCode="AU" term="%22Duh+EJ%22">Duh EJ</searchLink>; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address: eduh@jhmi.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228607908%22">Journal of controlled release : official journal of the Controlled Release Society</searchLink> [J Control Release] 2026 Jun 18; Vol. 397, pp. 115120. <i>Date of Electronic Publication: </i>2026 Jun 18.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science+Publishers%22">Elsevier Science Publishers </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8607908 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-4995 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201683659%22">01683659 </searchLink><i>NLM ISO Abbreviation: </i>J Control Release <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42314988
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.jconrel.2026.115120
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 115120
    Titles:
      – TitleFull: Intraocular delivery of crystalline sorafenib provides sustained, potent inhibition of wet age-related macular degeneration.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lu H
      – PersonEntity:
          Name:
            NameFull: Rakoski AI
      – PersonEntity:
          Name:
            NameFull: Ri K
      – PersonEntity:
          Name:
            NameFull: Zhou L
      – PersonEntity:
          Name:
            NameFull: Shi L
      – PersonEntity:
          Name:
            NameFull: Cho H
      – PersonEntity:
          Name:
            NameFull: Wu S
      – PersonEntity:
          Name:
            NameFull: Chen SS
      – PersonEntity:
          Name:
            NameFull: Neill AN
      – PersonEntity:
          Name:
            NameFull: Catazaro J
      – PersonEntity:
          Name:
            NameFull: Wong VW
      – PersonEntity:
          Name:
            NameFull: Yoo A
      – PersonEntity:
          Name:
            NameFull: Wilson DS
      – PersonEntity:
          Name:
            NameFull: Doloff JC
      – PersonEntity:
          Name:
            NameFull: Duh EJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 18
              M: 06
              Text: 2026 Jun 18
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1873-4995
          Numbering:
            – Type: volume
              Value: 397
          Titles:
            – TitleFull: Journal of controlled release : official journal of the Controlled Release Society
              Type: main
ResultId 1